Healthwell Acquisition I (Healthwell Acquisition I) Research & Development : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Healthwell Acquisition I Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Healthwell Acquisition I's Research & Development for the three months ended in Jun. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Healthwell Acquisition I Research & Development Historical Data

The historical data trend for Healthwell Acquisition I's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthwell Acquisition I Research & Development Chart

Healthwell Acquisition I Annual Data

Trend

Dec21

Dec22

Research & Development

Healthwell Acquisition I Quarterly Data
	Jan21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Research & Development	Get a 7-Day Free Trial					-	-	-	-	-

Healthwell Acquisition I Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Healthwell Acquisition I (NAS:HWEL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Healthwell Acquisition I Research & Development Related Terms

Thank you for viewing the detailed overview of Healthwell Acquisition I's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthwell Acquisition I (Healthwell Acquisition I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthwell Acquisition Corp I (NAS:HWEL) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Green Bay Road, Suite 227, Winnetka, IL, USA, 60093

Website

https://www.healthwellspac.com

Healthwell Acquisition Corp I is a blank check company.

Executives

Ellen Levy	director	C/O INSTRUCTURE, INC., 6330 SOUTH 3000 EAST, SUITE 700, SALT LAKE CITY UT 84121
George R Hornig	director	625 MADISON AVE SUITE 10-B, NEW YORK NY 10017
Christie Hefner	director	PLAYBOY ENT., INC. - H. SHAPIRO, 680 N. LAKE SHORE DRIVE, CHICAGO IL 60611
John L Maccarthy	director, 10 percent owner	333 WEST WACKER DRIVE, C/O NUVEEN INVESTMENTS, CHICAGO IL 60606
Healthwell Acquisition Corp. I Sponsor Llc	10 percent owner	1001 GREEN BAY RD. #227, WINNETKA IL 60093
Alyssa Rapp	director, 10 percent owner, officer: Chief Executive Officer	C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Curtis Feeny	director	C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Carl Allegretti	director	C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Tracy Wan	director, officer: Chief Financial Officer	C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093
Matt Wandoloski	director	C/O HEALTHWELL ACQUISITION CORP. I, 1001 GREEN BAY RD., #227, WINNETKA IL 60093